Looking for leads, investment insights, or competitive intelligence?
News about Thermo Fisher Scientific
Insights from our annual roundtable on the best stocks and the biggest risks.
Shifts in the biopharma economy have big ripple effects.
As it looks to become a one-stop shop for contract drug development and manufacturing.
With a divided court, IP cases move to the top of the list.
The company has also created a compliance and quality committee.